drugset / Trial / NCT00708006
A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of HGS1029 in subjects with advanced solid tumors and to determine a phase 2 dose.
Timeline
- Start
- 2008-05
- Primary completion
- 2011-12
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HGS1029 | Unknown | — | Intravenous |